Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06415058 · ClinicalTrials.gov registry record
Study to Investigate Blood Samples Drawn With the HemoIV System
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 19
- Enrollment target
NCT06415058 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT06415058 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The goal of this study is to compare blood drawn using a device called HemoIV to standard-of-care blood drawn from a vein in the arm or from an IV catheter. The HemoIV is a device that is attached to an IV line. This device allows for blood to be drawn while a patient is receiving IV fluids. The main questions it aims to answer are: * Will the HemoIV device allow blood to be drawn without having to stop IV fluids? * Will the HemoIV device provide the same laboratory results as blood draws done by current standard practice? Participants will: * Receive standard medical procedures and/or treatment; * Have a HemoIV device inserted into their IV line in one arm; * Have an blood drawn twice from the HemoIV and from an IV line or needle stick from a vein in the other arm. The second blood draw will be done about 8-22 hours after the first blood draw; * Have the device removed after the second blood draw; * Receive a phone call about 8 days later to see how you are doing.
Interventions
- DEVICE HemoIV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2024-05-02 |
| Est. Completion | 2025-02-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06415058
The ClinicalTrials.gov registry entry for NCT06415058 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HemoIV is the first listed.
NCT06415058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06415058 about?
NCT06415058 is a clinical study titled "Study to Investigate Blood Samples Drawn With the HemoIV System". The goal of this study is to compare blood drawn using a device called HemoIV to standard-of-care blood drawn from a vein in the arm or from an IV catheter. The HemoIV is a device that is attached to an IV line. This device allows for blood to be drawn while a patient is receiving IV fluids. The ma...
What is the current status of trial NCT06415058?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2024-05-02. Estimated completion is 2025-02-21.
What interventions are being tested in trial NCT06415058?
The interventions under investigation include: HemoIV (DEVICE).
Who is sponsoring clinical trial NCT06415058?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.